Eyebrow and Eyelash Loss in Patients With Cancer

Area of Science:

• Dermatology
• Oncology
• Hair Biology

Background:

• Cancer therapies commonly cause scalp hair loss.
• Limited data exist on chemotherapy-induced eyebrow and eyelash loss (madarosis).
• Madarosis significantly impacts patients' quality of life, leading to various cosmetic and medical interventions.

Purpose of the Study:

• To review current understanding of cancer treatment-induced madarosis.
• To explore existing and potential treatment and preventative strategies.
• To highlight the role of dermatologists in supportive oncodermatology.

Main Methods:

• Literature review of studies on cancer treatment side effects.
• Analysis of current management options for madarosis.
• Discussion of emerging preventative techniques.

Main Results:

• Eyebrow and eyelash loss (madarosis) is a recognized side effect of cancer treatments.
• Current treatments include makeup, tattoos, and medications, with varying efficacy.
• Preventative options like scalp cooling, cryotherapy, and vasoconstrictors show promise but require further study in this context.

Conclusions:

• There is a critical need for enhanced research into effective treatments and preventative measures for cancer-induced madarosis.
• Dermatologists are essential in providing supportive care for patients experiencing madarosis.
• Multidisciplinary approaches are necessary to improve patient outcomes and quality of life.